A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2.
Year: 1986
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: S A Rosenberg, M T Lotze, L M Muul, S Leitman, A E Chang, J T Vetto, C A Seipp, C Simpson
Institutions: National Cancer Institute, National Institutes of Health
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2412027286